G. Ralph - Concepedia

Author

G. Ralph

Also Known As

G Ralph, G Scott Ralph, G. Ralph, G. S. Ralph, G. Scott Ralph, G.S. Ralph, G.Scott Ralph, G. Scott Ralph, Gräsbeck Ralph

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Oxford BioMedica (United Kingdom)University of Bristol Centre National de la Recherche Scientifique CEA Paris-Saclay - Etablissement de Fontenay-aux-roses Commissariat à l'Énergie Atomique et aux Énergies Alternatives

About

G. Ralph is an author at Oxford BioMedica (United Kingdom) specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	2.1K
2	Social Sciences	7	7	796
3	Cell Biology	6	6	722
4	Engineering	1	1	41
5	Cellular Physiology	1	1	302

G. Ralph

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model G. Ralph, Pippa A. Radcliffe, Denise M. Day, Nature Medicine Neurodegenerative DiseasesAmyotrophic Lateral SclerosisRnai ProtectsGeneticsDegenerative Disease	2005	499
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial Stéphane Palfi, Jean Marc Gurruchaga, G. Ralph, The Lancet Gene TherapiesNeurodegenerative DiseasesDose EscalationPharmacologyClinical Trials	2014	432
Surface Expression of AMPA Receptors in Hippocampal Neurons Is Regulated by an NSF-Dependent Mechanism Jacques Noël, G. Ralph, Lisa Pickard, Neuron Nsf-dependent MechanismMolecular PhysiologyNeurophysiologyPhysiologyNeurotransmitter	1999	302
Removal of AMPA Receptors (AMPARs) from Synapses Is Preceded by Transient Endocytosis of Extrasynaptic AMPARs Michael C. Ashby, Sarah A. De La Rue, G. Ralph, Journal of Neuroscience Synaptic TransmissionNeurotransmitterNeurotransmissionSynaptic SignalingSocial Sciences	2004	241
Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy Mimoun Azzouz, Thanh T. Le, G. Ralph, Journal of Clinical Investigation ImmunologyViral PathogenesisSma Type 1NeuroregenerationLentivector-mediated Smn Replacement	2004	198
Dopamine Gene Therapy for Parkinson’s Disease in a Nonhuman Primate Without Associated Dyskinesia Béchir Jarraya, Sabrina Boulet, G. Ralph, Science Translational Medicine	2009	177
Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease Stéphane Palfi, Jean Marc Gurruchaga, H. Lepetit, Human Gene Therapy Clinical Development Phase I/ii StudyDopamine ReceptorsPharmacotherapyTranslational MedicineClinical Trials	2018	137
Separate elements of episodic memory subserved by distinct hippocampal–prefrontal connections G.R. Barker, Paul J. Banks, Hannah Scott, Nature Neuroscience Separate ElementsCognitive ScienceMemory SystemMemoryCognition	2017	123
Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons Hiang Khoon Tan, Darren J. Heywood, G. Ralph, Molecular and Cellular Neuroscience Molecular NeuroscienceMetalloproteinase 1ApoptosisTissue InhibitorMetalloprotein	2003	85
Lentiviral-Mediated Delivery of Bcl-2 or GDNF Protects against Excitotoxicity in the Rat Hippocampus Liang‐Fong Wong, G. Ralph, Lucy E. Walmsley, Molecular Therapy	2004	63

Page 1